| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $305.9M | — | +10.7% |
| Cost of Revenue | $62.7M | — | +3.4% |
| Gross Profit | $243.2M | — | +12.8% |
| R&D Expense | $75.9M | — | +5.0% |
| SG&A Expense | $38.0M | — | +0.3% |
| Operating Income | $27.4M | — | +333.0% |
| Interest Expense | $2.4M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $378.8M | +1.0% | -45.1% |
| Short-term Investments | $98.2M | -4.6% | -2.6% |
| Accounts Receivable | $192.3M | -40.8% | +8.0% |
| Current Assets | $765.6M | -14.1% | -27.5% |
| Total Assets | $1.42B | -8.0% | -13.4% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $140.2M | — | +10.3% |
| Capital Expenditures | $1.3M | — | +264.8% |
| Investing Cash Flow | -$6.1M | — | +40.8% |
| Financing Cash Flow | -$125.8M | — | -103.7% |
| Free Cash Flow | $138.9M | — | +9.6% |
| -10.9% |
| Pre-tax Income | $27.5M | — | +109.3% |
| Income Tax | $9.8M | — | +97.6% |
| Net Income | $17.7M | — | +116.3% |
| EPS (Basic) | $0.09 | — | +350.0% |
| EPS (Diluted) | $0.08 | — | +300.0% |
| $717.0M |
| -10.7% |
| -18.2% |
| Long-term Debt | $451.6M | +0.1% | +0.5% |
| Total Liabilities | $1.26B | -6.4% | -11.5% |
| Stockholders' Equity | -$338.4M | -13.1% | -20.8% |